Flor Juarez-Hernandez
Clinical Research Coordinator
Ob/Gyn, Reproductive Sciences
School of Medicine

Education & Training

Show all (1) Hide

• Diversity, Equity, and Inclusion Champion Training University of California 2019

Publications (6)

Top publication keywords:
TamoxifenInfertility, FemaleFertilization in VitroSperm Injections, IntracytoplasmicPreimplantation DiagnosisFollicle Stimulating Hormone, HumanFollicle Stimulating HormoneOvarian Hyperstimulation SyndromeFertility PreservationInfertility, MaleCryopreservationOocytesEmbryo, MammalianGonadotropinsPregnancy Rate

• Fertility preservation before breast cancer treatment appears unlikely to affect disease-free survival at a median follow-up of 43 months after fertility-preservation consultation.
  Cancer 2019 Letourneau JM, Wald K, Sinha N, Juarez-Hernandez F, Harris E, Cedars MI, McCulloch CE, Dolezal M, Chien AJ, Rosen MP
• Decision-making surrounding the use of preimplantation genetic testing for aneuploidy reveals misunderstanding regarding its benefit.
  Journal of assisted reproduction and genetics 2018 Quinn MM, Juarez-Hernandez F, Dunn M, Okamura RJ, Cedars MI, Rosen MP
• Hormone concentrations of dominant follicles in the TALES randomized controlled trial comparing letrozole with tamoxifen.
  Journal of assisted reproduction and genetics 2022 Wang A, Letourneau JM, Juarez-Hernandez F, Abel MK, Mok-Lin E, Rosen MP
• Microfluidic preparation of spermatozoa for ICSI produces similar embryo quality to density-gradient centrifugation: a pragmatic, randomized controlled trial.
  Human reproduction (Oxford, England) 2022 Quinn MM, Ribeiro S, Juarez-Hernandez F, Simbulan RK, Jalalian L, Cedars MI, Rosen MP
• Triggering with 1,500 IU of human chorionic gonadotropin plus follicle-stimulating hormone compared to a standard human chorionic gonadotropin trigger dose for oocyte competence in in vitro fertilization cycles: a randomized, double-blinded, controlled noninferiority trial.
  Fertility and sterility 2022 Anaya Y, Cakmak H, Mata DA, Letourneau J, Zhang L, Lenhart N, Juarez-Hernandez F, Jalalian L, Cedars MI, Rosen M
• Concomitant tamoxifen or letrozole for optimal oocyte yield during fertility preservation for breast cancer: the TAmoxifen or Letrozole in Estrogen Sensitive tumors (TALES) randomized clinical trial.
  Journal of assisted reproduction and genetics 2021 Letourneau J, Juarez-Hernandez F, Wald K, Ribeiro S, Wang A, McCulloch CE, Mok-Lin E, Dolezal M, Chien AJ, Cedars MI, Rosen M